JetBlue Airways Corporation vs Liquidia Corporation Common Stock — how do they compare? JetBlue Airways Corporation trades at $3.06 (market cap $1.26B), while Liquidia Corporation Common Stock trades at $34.17 (market cap $2.40B). The key difference: Liquidia Corporation Common Stock is the larger of the two by market cap, and Liquidia Corporation Common Stock is trading nearer its 52-week high, JetBlue Airways Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold JetBlue Airways Corporation for 44 Days and Liquidia Corporation Common Stock for 0 Days on average.
| JBLU | LQDA | |
|---|---|---|
Market Cap | $1.26B | $2.40B |
Volume | 40,642,525 | 2,857,547 |
Sector | Industrials | Health |
52-Week High | $6.46 | $91.03 |
52-Week Low | $3.01 | $22.02 |
Typical Hold Time | 44 Days | 0 Days |
Enterprise Value | $8.63B | $2.30B |
Signals from Pluang's Aura AI — not financial advice
JetBlue (JBLU) trades at $3.01, down 16.85% in the last 24 hours, reflecting significant bearish pressure. The stock exhibits weak fundamentals with a negative net income margin of -9.32% and consecutive quarterly losses, though it beat EPS expectations in Q2 2026. Technical indicators are predominantly bearish, with the stock trading near key support levels. Recent news highlights expansion efforts like new routes to Colombia and the launch of BlueFirst premium seating, aiming to boost revenue amid industry challenges.
The outlook remains challenging due to persistent losses, high debt levels, and elevated fuel costs. While analyst consensus suggests a hold rating with a $5.89 price target implying potential upside, risks from competitive pressures and macroeconomic factors dominate. Investment appeal is limited to speculative positions betting on a operational turnaround despite current headwinds.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →